Home / news / Corona … European restrictions on the distribution of vaccines, and the Health Organization warns of an international conflict over its supplies

Corona … European restrictions on the distribution of vaccines, and the Health Organization warns of an international conflict over its supplies

The European Union decided to prevent companies that produce Corona virus vaccines from exporting vaccines outside its countries without a prior license, while the World Health Organization warned of an international conflict over vaccine supplies.

Vladis Dombrowskis, Vice President of the European Commission, said that the aim of this decision is to secure an adequate number of vaccines for citizens of European Union countries, calling on pharmaceutical companies to respect the schedules for delivering vaccines.

For his part, the Director-General of the World Health Organization, Dr. Tedros Adhanom Ghebreyesus, said that vaccines against the epidemic offer a second chance to control the epidemic, and therefore the world should not squander them.

And he added – in a press conference at the organization’s headquarters in Geneva today, Friday, on the occasion of the one-year anniversary of the declaration of an international health emergency due to the epidemic – that vaccines would make everyone aware of inequality, indicating that the national view of vaccines may be useful to some countries in the long term. Short; But it will not be beneficial in the long run, because the epidemic will not end unless it ends all over the world.

The Director-General of the World Health Organization called on the people of countries that receive large quantities of vaccines without looking to other countries, to demand their governments to share vaccines with other countries.

Astrazinic fertilization

In the midst of an escalating controversy over late delivery of doses, the European Union gave its approval to use the AstraZeneca vaccine for the Coronavirus.

On Friday, the European Medicines Agency approved the AstraZeneca vaccine for all people over the age of 18, saying it believed the vaccine was also suitable for the elderly, at a time when Brussels criticized the company for its delay in deliveries.

The third AstraZeneca vaccine, which is getting the green light from the European Medicines Agency, became the “Pfizer-BioNTech” vaccine on December 21 and “Moderna” on January 6.

The Swedish-British group AstraZeneca has been angering European Union leaders for days. Due to delays in vaccine deliveries.

For its part, Hungary, which criticizes Brussels for its “slowness”, has become the first country in the European Union to authorize the use of the Chinese laboratory “SinoPharm”, after its authorization last week to use the Russian “Sputnik-V” vaccine.

This hidden conflict over vaccines comes against the backdrop of the high number of infections with the disease, and the growing anxiety in Europe and abroad, where mutated versions of the virus are rampant, which raises questions about the effectiveness of vaccines against them.

In the context of this dispute, the European Commission published, on Friday, the contract signed last year with AstraZeneca to pre-order doses of its vaccine. However, entire sections are covered for reasons of confidentiality.

The Medicines Agency confirmed that the Pfizer-Pontec vaccine had no connection with the deaths. (European News Agency)

Relation of the vaccine to deaths

In the same context, the European Union Medicines Agency confirmed today that there is no connection between the “Pfizer-BioNTech” vaccine and the deaths recorded among people who have received it, and that it does not cause new side effects, based on the first data. Associated with its launch.

The announcement by the Amsterdam-based agency came after reports reported that dozens, especially the elderly, died in Norway and other European countries after receiving the first dose of it.

On the other hand, the American company “Johnson & Johnson” announced that it had developed a single-dose vaccine against “Covid-19”, with an effectiveness rate of 72% in the United States, and a general effectiveness rate of 66% in protection from moderate to moderate cases. Acute disease.

The company will require the US Centers for Disease Control and Prevention for a permit for emergency use by February, and it aims to have the vaccines ready for shipment shortly thereafter.

More than two million deaths

The new Corona virus has killed two million 191,865 people in the world, since the WHO office in China reported the emergence of the disease at the end of December 2019, and the United States is the country most affected by the epidemic, followed by Brazil, Mexico, India and the United Kingdom.

Today, Friday, the 27 European Union countries recommended tightening travel restrictions, including not making unnecessary travel to and from regions with high rates of infection with the Coronavirus.

While the United Kingdom closed its borders, today, to arrivals from the UAE, Burundi and Rwanda, with the aim of preventing the arrival of mutated versions of the virus.

On the other hand, today, a team of experts led by the World Health Organization, which is investigating the origin of Covid-19, visited a hospital in the Chinese city of Wuhan, which was one of the first hospitals that treated patients in the first days of the outbreak.

After meeting with Chinese scientists earlier in the day, Friday, the team went to the “Chinese-Western Medicine Integrative Medicine” hospital in Hubei province.




Source link

Leave a Reply